Role of Blood Stasis Syndrome of Kampo Medicine in the Early Pathogenic Stage of Atherosclerosis: A Retrospective Cross-Sectional Study

Table 3

Blood test data of the NBS group and BS syndrome group (n = 38).

Variables	Units	NBS group (n = 18)	BS syndrome group (n = 20)	value
TG	mg/dL	114.4 ± 63.0	123.4 ± 61.4	0.67^a
HDL cholesterol	mg/dL	65.6 ± 21.0	56.7 ± 11.3	0.12^a
LDL cholesterol	mg/dL	122.8 ± 41.1	118.9 ± 31.7	0.75^a
HbA1c	NGSP, %	6.2 ± 0.9	6.6 ± 0.8	0.21^a
FPG	mg/dL	113.9 ± 24.6	125.9 ± 31.6	0.22^a
IRI	μU/mL	4.3 ± 2.4	8.8 ± 10.0	0.08^a
HOMA-R		1.3 ± 0.8	3.4 ± 5.4	0.11^a
HOMA-β	%	34.5 ± 26.2	42.3 ± 29.7	0.41^a
hsCRP	mg/dL	0.11 ± 0.18	0.31 ± 0.52	0.13^a

NBS: non-blood stasis; BS: blood stasis; TG: triglyceride; HDL: high-density lipoprotein; LDL: low-density lipoprotein; HbA1c: hemoglobin A1c; FPG: fasting plasma glucose; IRI: immunoreactive insulin; HOMA-R: homeostasis model assessment ration; HOMA-β: homeostasis model assessment of beta-cell function; hsCRP: high-sensitivity C-reactive protein. ^aComparison between the groups by Student’s t-test. Data are expressed as the mean ± standard deviation.